Related Experiment Video
Updated: Mar 13, 2026

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
Role of Microvesicles From Bone Marrow Mesenchymal Stem Cells in Acute Pancreatitis
Guojian Yin1, Guoyong Hu, Rong Wan
1From the *Department of Gastroenterology, the Second Affiliated Hospital of Soochow University, Suzhou; †Department of Gastroenterology, Shanghai First People's Hospital, Shanghai Jiaotong University School of Medicine; and ‡Department of Gastroenterology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Objectives:
Mesenchymal stem cells (MSCs) have shown an obvious protective effect on acute pancreatitis (AP). The purpose of the present study was to analyze the effect of bone marrow MSC-derived microvesicles (bmMSC-MVs) on AP and explore the underlying mechanisms.
Methods:
Bone marrow MSCs and bmMSC-MVs were isolated from Sprague-Dawley rats. Cerulein-induced mild AP (MAP) and sodium taurocholate-induced severe AP (SAP) were used as AP models in vivo and in vitro. Pancreatic injury was evaluated by measuring serum levels of amylase, lipase, chemokines, and interleukins, and by pancreatic histology, reverse transcription-polymerase chain reaction, Western blotting, and immunohistochemistry. The effects of bmMSC-MVs on the survival rates of pancreatic acinar cells in vitro were also assessed.
Results:
Bone marrow MSC-MVs attenuated acute pancreatic injury in MAP and SAP by regulating IL-1α, IL-6, and TNF-α, and dramatically attenuated the nuclear translocation of NF-κB p65 in MAP and SAP. Bone marrow MSC-MVs improved the survival rates of pancreatic acinar cells in MAP and SAP models in vitro.
Conclusions:
Bone marrow MSC-MVs played a protective role in AP by reducing the levels of proinflammatory cytokines and regulating the nuclear translocation of NF-κB p65. Bone marrow MSC-MVs could be developed as a strategy for the clinical treatment of SAP.
Insights
Bone marrow microvesicles derived from mesenchymal stem cells protect against acute pancreatitis. These microvesicles reduce inflammation and improve pancreatic cell survival, offering a potential treatment for severe acute pancreatitis.
Area of Science:
- Regenerative Medicine
- Cell Biology
- Gastroenterology
Background:
- Mesenchymal stem cells (MSCs) demonstrate protective effects in acute pancreatitis (AP).
- Investigating cell-free therapeutic approaches using MSC-derived products is crucial for AP treatment.
- Microvesicles (MVs) are emerging as key mediators of MSC therapeutic potential.
Purpose of the Study:
- To evaluate the therapeutic effect of bone marrow MSC-derived microvesicles (bmMSC-MVs) on acute pancreatitis (AP).
- To elucidate the underlying mechanisms by which bmMSC-MVs exert their protective effects in AP models.
Main Methods:
- bmMSC-MVs were isolated from Sprague-Dawley rats.
- Acute pancreatitis (AP) models were established in vivo (cerulein-induced mild AP and sodium taurocholate-induced severe AP) and in vitro.
- Pancreatic injury markers (serum amylase, lipase, cytokines) and NF-κB signaling were assessed.
Main Results:
- bmMSC-MVs significantly attenuated pancreatic injury in both mild and severe AP models.
- Treatment with bmMSC-MVs reduced levels of pro-inflammatory cytokines (IL-1α, IL-6, TNF-α).
- bmMSC-MVs inhibited NF-κB p65 nuclear translocation and improved pancreatic acinar cell survival in vitro.
Conclusions:
- Bone marrow MSC-derived microvesicles exhibit a protective role in acute pancreatitis.
- bmMSC-MVs reduce inflammation by decreasing pro-inflammatory cytokines and regulating NF-κB signaling.
- bmMSC-MVs represent a promising cell-free therapeutic strategy for severe acute pancreatitis (SAP).
Related Concept Videos
Mesenchymal Stem Cells
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

